Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy. 2010

Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
Universidade de São Paulo, Ribeirão Preto-SP, Brazil. amfrosel@fmrp.usp.br

Antiphospholipid antibodies, such as anti-beta2-glycoprotein I (beta2GPI), are present in multibacillary leprosy (MB) patients; however, MB patients do not usually present with antiphospholipid antibody syndrome (APS), which is characterized by thromboembolic phenomena (TEP). Rare cases of TEP occur in leprosy patients, but the physiopathology of this condition remains unclear. In this case-control study, we examined whether single-nucleotide polymorphisms (SNPs) of the beta2GPI gene contributed to the risk of leprosy and APS co-morbidity. SNPs Ser88Asn, Leu247Val, Cys306Gly and Trp316Ser were identified in 113 Brazilian leprosy patients. Additionally, anti-beta2GPI antibodies and plasma concentrations of beta2GPI were quantified. The Ser88Asn, Cys306Gly and Trp316Ser SNPs were not risk factors for APS in leprosy. A higher frequency of Val/Val homozygosity was observed in leprosy patients compared to controls (36 vs. 5%; P < 0.001). Forty-two percent of MB and 17% of paucibacillary leprosy patients were positive for anti-beta2GPI IgM (P = 0.014). There was no correlation between SNP Ser88Asn or Cys306Gly and anti-beta2GPI antibody levels. In MB patients with positive anti-beta2GPI IgM, the frequency of Val/Val homozygosity was higher than in controls (32 vs. 15%; P = 0.042). The frequency of the mutant allele Ser316 was higher in MB patients with positive rather than negative anti-beta2GPI IgM levels (6 vs. 0%; P = 0.040) and was greater than in the control group (6 vs. 1%; P = 0.034). The studied polymorphisms did not influence the plasma concentrations of beta2GPI. These results suggest that Leu247Val and Trp316Ser SNPs may represent genetic risk factors for anti-beta2GPI antibody production in MB patients.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
December 1998, Leprosy review,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
August 1999, Rheumatology (Oxford, England),
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
January 1995, Clinical reviews in allergy & immunology,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
November 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
December 1998, American journal of reproductive immunology (New York, N.Y. : 1989),
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
January 1995, Clinical reviews in allergy & immunology,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
January 1994, Annales de biologie clinique,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
February 2005, Autoimmunity,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
October 2004, Experimental gerontology,
Maria José Franco Brochado, and José Fernando C Figueiredo, and Celso Teixeira Mendes-Junior, and Paulo Louzada-Junior, and Olivia Makiyama Kim, and Ana Maria Roselino
December 1997, British journal of rheumatology,
Copied contents to your clipboard!